Company / Free Cash Flow
PTC Therapeutics, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$702.3M
FY2025
5-year range
-$211.9M / $702.3M
FY2021-FY2025
Trend
+715.1%
vs FY2024
Sector context
#21 of 194
Health Care
What the data says
Free Cash Flow changed +715% YoY in FY2025, a notable deviation from the 9-year average annual change of +25%.
Based on SEC 10-K filings.
$702M in FY2025. Top quartile in the Health Care sector.
Improved from -$187M to $702M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 194This company $702.3M Sector average $470.8M
▼
+49.2% above sector average
Key checks
Key Insights
- PTC Therapeutics, Inc.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 715.1% year-over-year.
- Ranks #21 out of 194 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $702.3M | +715.1% |
| FY2024 | -$114.2M | +38.9% |
| FY2023 | -$186.9M | +11.8% |
| FY2022 | -$211.9M | -88.5% |
| FY2021 | -$112.4M | -223.6% |
| FY2020 | -$34.7M | +69.1% |
| FY2019 | -$112.4M | -223.6% |
| FY2018 | -$34.7M | -163.9% |
| FY2017 | -$13.2M | +87.5% |
| FY2016 | -$105.3M | +17.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026